Safety of Sabin Inactivated Poliovirus Vaccine in Adults, Children and Infants and Lot Consistency Immunogenicity, and Safety of the msIPV in 2 Months Old Infants

NCT05386810 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1572

Enrollment

INDUSTRY

Sponsor class

Conditions

Poliomyelitis

Interventions

BIOLOGICAL: Experimental vaccine
BIOLOGICAL: IPV control vaccine
BIOLOGICAL: single-person sIPV control vaccine

Sponsor

Sinovac Biotech Co., Ltd